Wonbiogen Co Ltd
KOSDAQ:307280
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| KR |
W
|
Wonbiogen Co Ltd
KOSDAQ:307280
|
49.2B KRW |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
187.8B USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.8B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
137.1B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
135.7B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
129.3B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
57.6B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.1B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
55.5B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.6B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
36.8B USD |
Loading...
|
Market Distribution
| Min | -168 471.3% |
| 30th Percentile | -2.9% |
| Median | 1.9% |
| 70th Percentile | 5.8% |
| Max | 21 012.5% |
Other Profitability Ratios
Wonbiogen Co Ltd
Glance View
Wonbiogen Co., Ltd. engages in the research and development of biocompatible medical materials. The company is headquartered in Gumi, Gyeongsangbuk-Do. The company went IPO on 2018-12-05. The firm provides medical products including dressing material used for lower leg ulcers, pressure ulcers and surgical wounds; dressing material for secretions absorption and wound area protection; fixing band for bandages, gauze, catheters, along with others.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Wonbiogen Co Ltd is 19.2%, which is above its 3-year median of 16.9%.
Over the last 3 years, Wonbiogen Co Ltd’s Net Margin has increased from 12.7% to 19.2%. During this period, it reached a low of 12% on Dec 31, 2022 and a high of 19.2% on Oct 30, 2025.